Business Description
Tuoxin Pharmaceutical Group Co Ltd
ISIN : CNE100004YC3
Share Class Description:
SZSE:301089: Class ACompare
Compare
Traded in other countries / regions
301089.China IPO Date
2021-10-27Description
Tuoxin Pharmaceutical Group Co Ltd, formerly Xinxiang Tuoxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical synthesis and biological fermentation nucleoside APIs and pharmaceutical intermediates.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.9 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 13.65 | |||||
| Beneish M-Score | -0.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6 | |||||
| 3-Year EBITDA Growth Rate | 17.9 | |||||
| 3-Year EPS without NRI Growth Rate | 15.3 | |||||
| 3-Year Book Growth Rate | 34.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.85 | |||||
| 9-Day RSI | 28.18 | |||||
| 14-Day RSI | 34.38 | |||||
| 6-1 Month Momentum % | 4.52 | |||||
| 12-1 Month Momentum % | -44.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.04 | |||||
| Quick Ratio | 3.87 | |||||
| Cash Ratio | 2.58 | |||||
| Days Inventory | 194.98 | |||||
| Days Sales Outstanding | 112.78 | |||||
| Days Payable | 129.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.86 | |||||
| Forward Dividend Yield % | 0.86 | |||||
| 5-Year Yield-on-Cost % | 0.82 | |||||
| 3-Year Average Share Buyback Ratio | -10.2 | |||||
| Shareholder Yield % | 0.82 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.28 | |||||
| Operating Margin % | -17.49 | |||||
| Net Margin % | -17.53 | |||||
| FCF Margin % | 2.51 | |||||
| ROE % | -4.54 | |||||
| ROA % | -4.03 | |||||
| ROIC % | -5.44 | |||||
| ROC (Joel Greenblatt) % | -7.81 | |||||
| ROCE % | -4.74 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 34.16 | |||||
| PS Ratio | 9.81 | |||||
| PB Ratio | 2.37 | |||||
| Price-to-Tangible-Book | 2.5 | |||||
| Price-to-Free-Cash-Flow | 166.95 | |||||
| Price-to-Operating-Cash-Flow | 41.8 | |||||
| EV-to-EBIT | -39.73 | |||||
| EV-to-EBITDA | -39.73 | |||||
| EV-to-Revenue | 7.45 | |||||
| EV-to-FCF | 313.81 | |||||
| Price-to-Projected-FCF | 2.83 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 7.15 | |||||
| Price-to-Net-Cash | 20.69 | |||||
| Earnings Yield (Greenblatt) % | -2.52 | |||||
| FCF Yield % | 0.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tuoxin Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 415.136 | ||
| EPS (TTM) (Â¥) | -0.577 | ||
| Beta | 0.49 | ||
| Volatility % | 45.31 | ||
| 14-Day RSI | 34.38 | ||
| 14-Day ATR (Â¥) | 1.360782 | ||
| 20-Day SMA (Â¥) | 32.2595 | ||
| 12-1 Month Momentum % | -44.06 | ||
| 52-Week Range (Â¥) | 25.95 - 57.45 | ||
| Shares Outstanding (Mil) | 126.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tuoxin Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tuoxin Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tuoxin Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Tuoxin Pharmaceutical Group Co Ltd(SZSE:301089)'s stock price today?
The current price of SZSE:301089 is ¥29.38. The 52 week high of SZSE:301089 is ¥57.45 and 52 week low is ¥25.95.
When is next earnings date of Tuoxin Pharmaceutical Group Co Ltd(SZSE:301089)?
The next earnings date of Tuoxin Pharmaceutical Group Co Ltd(SZSE:301089) is .
Does Tuoxin Pharmaceutical Group Co Ltd(SZSE:301089) pay dividends? If so, how much?
The Dividend Yield %  of Tuoxin Pharmaceutical Group Co Ltd(SZSE:301089) is 0.86% (As of Today), Highest Dividend Payout Ratio of Tuoxin Pharmaceutical Group Co Ltd(SZSE:301089) was 0.22. The lowest was 0.05. And the median was 0.13. The  Forward Dividend Yield % of Tuoxin Pharmaceutical Group Co Ltd(SZSE:301089) is 0.86%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers